Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-106,497
Closed -$4.6M – 659
2022
Q4
$4.6M Buy
+106,497
New +$4.21M 0.08% 218
2021
Q1
– Sell
-80,409
Closed -$2.42M – 844
2020
Q4
$2.42M Buy
+80,409
New +$2.37M 0.05% 333
2020
Q3
– Sell
-70,100
Closed -$1.81M – 354
2020
Q2
$1.81M Buy
+70,100
New +$1.86M 0.04% 236
2015
Q3
– Sell
-1,530,148
Closed -$34.3M – 606
2015
Q2
$34.3M Sell
1,530,148
-305,143
-17% -$7.31M 0.28% 102
2015
Q1
$44M Buy
1,835,291
+1,049,119
+133% +$26M 0.43% 63
2014
Q4
$20.8M Sell
786,172
-17,454
-2% -$448K 0.36% 77
2014
Q3
$19.5M Sell
803,626
-152,538
-16% -$3.57M 0.34% 89
2014
Q2
$24.9M Buy
+956,164
New +$24.4M 0.16% 62

Other funds holding EXC

UBS O'Connor's EXC Position: Q1 2023 in Review

UBS O'Connor sold out of Exelon (EXC) in Q1 2023, closing a stake of 106,497 shares — an estimated $4.6M sold.

UBS O'Connor first reported a position in EXC in Q2 2014 and held it in 8 quarters. The position peaked at $44M in Q1 2015. 1,000 funds tracked by Wall St. Rank hold EXC as of Q1 2023.

  • UBS O'Connor reported no remaining Exelon position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 106,497 Exelon shares in Q1 2023, an estimated $4.6M.
  • UBS O'Connor first reported a position in Exelon in Q2 2014 and held it in 8 quarters.
  • UBS O'Connor's Exelon position peaked at $44M in Q1 2015.
  • 1,000 funds tracked by Wall St. Rank held Exelon as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.